Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heparin Induced Thrombocytopenia”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Large-scale testing (Phase 3)Ended earlyNCT01598168
What this trial is testing

Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia

Who this might be right for
Heparin-induced Thrombocytopenia
McMaster University 22
Not applicableUnknownNCT04751357
What this trial is testing

Argatroban Monitoring in Critically Ill Patients: Evaluation of a Novel Ecarin-based Bedside Test

Who this might be right for
Heparin-induced Thrombocytopenia
Medical University of Vienna 21
Not applicableUnknownNCT05783895
What this trial is testing

Comparison of Pre-test Probability Model for Heparin-induced Thrombocytopenia in Post-operative Cardiac Surgery

Who this might be right for
Heparin-induced Thrombocytopenia
Central Hospital, Nancy, France 200
Not applicableUnknownNCT00198575
What this trial is testing

A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients

Who this might be right for
Heparin-Induced Thrombocytopenia
Ministry of Health, Labour and Welfare, Japan 1,500
Testing effectiveness (Phase 2)Temporarily pausedNCT02501434
What this trial is testing

Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin

Who this might be right for
Aneurysmal Subarachnoid HemorrhageNeurobehavioral ManifestationsVasospasm, Intracranial+2 more
Robert F. James 88
Large-scale testing (Phase 3)Ended earlyNCT03809481
What this trial is testing

Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban

Who this might be right for
Heparin-induced Thrombocytopenia
Aspen Global Incorporated 7
Early research (Phase 1)Study completedNCT00412464
What this trial is testing

Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis

Who this might be right for
ThrombosisHeparin-induced Thrombocytopenia
Children's Hospital Los Angeles 24
Testing effectiveness (Phase 2)Study completedNCT00861692
What this trial is testing

Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II

Who this might be right for
Heparin-induced Thrombocytopenia Type II
Tanabe Pharma Corporation 20
Testing effectiveness (Phase 2)Ended earlyNCT03594045
What this trial is testing

Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)

Who this might be right for
Heparin-induced ThrombocytopeniaHeparin-induced Thrombocytopenia and Thrombosis
Massachusetts General Hospital 5
Not applicableUnknownNCT03148912
What this trial is testing

Optimizing the Diagnosis of Heparin Induced Thrombocytopenia

Who this might be right for
Heparin-induced Thrombocytopenia (HIT)
Ottawa Hospital Research Institute 180
Post-approval studies (Phase 4)Study completedNCT00913133
What this trial is testing

Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis

Who this might be right for
Thrombosis
Canyon Pharmaceuticals, Inc. 516
Post-approval studies (Phase 4)Ended earlyNCT00787332
What this trial is testing

A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome

Who this might be right for
Suspected Heparin-Induced Thrombocytopenia
Canyon Pharmaceuticals, Inc. 16
Not applicableUnknownNCT05586854
What this trial is testing

Multicenter Study on Dialysis Modalities for End-stage Chronic Renal Failure Patients With Heparin-induced Thrombocytopenia

Who this might be right for
Dialysis; ComplicationsHeparin-induced ThrombocytopeniaChronic Renal Failure
Ramsay Générale de Santé 20
Not applicableStudy completedNCT05439265
What this trial is testing

EMR Tool Impact on HIT Documentation and Management

Who this might be right for
HeparinThrombocytopeniaElectronic Health Records
Rush University Medical Center 128
Not applicableUnknownNCT00946400
What this trial is testing

Validating 4Ts for Heparin Induced Thrombocytopenia (HIT)

Who this might be right for
Heparin-Induced Thrombocytopenia
Medstar Health Research Institute 500
Not applicableUnknownNCT03269019
What this trial is testing

Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia

Who this might be right for
Heparin-Induced ThrombocytopeniaThrombosisBiomarkers
Wuhan Asia Heart Hospital 200
Not applicableStudy completedNCT01654848
What this trial is testing

Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients

Who this might be right for
Heparin-induced ThrombocytopeniaLiver Transplantation
CHIR-Net 39
Not applicableStudy completedNCT01178333
What this trial is testing

Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study

Who this might be right for
Heparin Induced Thrombocytopenia
Carelon Research 668
Not applicableStudy completedNCT02526485
What this trial is testing

Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2

Who this might be right for
Heparin-induced Thrombocytopenia
Vanderbilt University Medical Center 15
Early research (Phase 1)Study completedNCT00489437
What this trial is testing

Heparin-Induced Thrombocytopenia Score Card Study

Who this might be right for
Heparin-Induced Thrombocytopenia
McMaster University 536
Load More Results